C1QTNF3 and diabetic kidney disease: Furthermore, CTRP3 and CTRP6 have been reported to be potential therapeutic targets for diabetic nephropathy, exerting their effects via the regulation of glomerular mesangial cell function [30,31], indicating that the CTRP family of adipokines may be involved in the regulation of the urinary system.